POLITICO - The payment deal for Kymriah therapy drew internal HHS scrutiny and is the target of current congressional investigations of Swiss drug giant Novartis. The company's pivotal study of the drug's in children with acute lymphoblastic leukemia found that at one year, about one out of every three patients the government would be covering would get sick again, said INMACULADA HERNANDEZ (HPM '16).
ASPPH FRIDAY LETTER - In the first 90 days of concurrent opioid and benzodiazepine use, the risk of opioid-related overdose increases five-fold compared to opioid-only use among Medicare recipients. "Having multiple prescribers who are not in communication increases the risk for overdose,” says HPM's YUTING ZHANG. "Policy interventions should focus on preventing concurrent exposure,” says INMACULADA HERNANDEZ (HPM '16).
JOHANNA BELLON (HPM '15) is the Senior Director of Quality Analytics and Performance at the UPMC Wolff Center. UPMC is a 40+ hospital integrated finance and delivery system with over 3,500 providers and a multitude of clinical sites.
INMACULADA HERNANDEZ (HPM ‘16) is working on developing her own independent research program at Pitt's School of Pharmacy, which is built at the intersection of pharmaceutical health services and outcomes research, pharmacoepidemiology, pharmacoeconomics and pharmaceutical policy.
TRI LE (HPM '16) is currently a research analyst in the Quality Measurement and Health Policy program at RTI International. He is part of a team that develops, maintains, re-evaluates, and implements outcome, structural, process, and composite quality measures for the Long-Term Care Hospital (LTCH), Inpatient Rehabilitation Facility (IRF), Skilled Nursing Facility (SNFs), and nursing home post-acute care quality programs.
CARROLINE LOBO (HPM '17) joined Cepheid, a bio-molecular diagnostics company located in the heart of Silicon Valley, in December 2017. Carroline reports to the vice president of Cepheid’s Government Affairs division, providing expert analytical support to guide reimbursement and market access related decisions.
More Pitt Public Health News
ANA PROGOVAC (HPM '15) is currently an instructor of psychiatry at Harvard Medical School and senior scientist at the Health Equity Research Lab at Cambridge Health Alliance, which is a health system in Massachusetts serving Cambridge, Somerville, and Boston's Metro North Region.